Table 2.
Continued
| Gene ID | FPKM/Average | Literatures (TITLE/ABSTRACT must include the keywords) | Literature (IF is in the top 5) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cell Type | Full Name | Abbreviation | iPSC | TM Progenitor | HTM | Keywords | Stem Cell Differentiation | Trabecular Meshwork | Stem Cell Differentiation | Trabecular Meshwork |
| HTM | TGF-beta receptor type-2 | TGFBR2 | 2.8 | 50.0 | 163.2 | Transforming growth factor | 97 | 136 | Bonauer et al. 2009,42 Jia et al. 2017,43 Wandzioch and Zaret 2009,44 Xu et al. 2002,45 Zhang et al. 2015.46 | Agarwal and Agarwal 2018,47 Gabelt and Kaufman 2005,48 Liton et al. 2005;Luna et al. 2011,49 Raghunathan et al. 2015,50 Tamm 2002,51 Wahlig, Lovatt, and Mehta 2018.52 |
| Transforming growth factor beta receptor type 3 | TGFBR3 | 2.4 | 12.6 | 13.4 | 97 | 136 | ||||
| Prostaglandin F2-alpha receptor | PTGFR | 0.1 | 2.6 | 11.4 | Prostaglandin | 7 | 105 | Ludin et al. 2014,60 North et al. 2007,61 Sancilio et al. 2019,62 Wong et al. 2016,63 Zhang et al. 2017.64 | Barraza, McLaren, and Poeschla 2010,65 Garnock-Jones 2014,66 Hoy 2018,67 Impagnatiello et al. 2019,68 Narayanaswamy et al. 2015.69 | |
| Prostaglandin E2 receptor EP4 subtype | PTGER4 | 0.3 | 2.5 | 1.0 | 7 | 105 | ||||
| EGF-like repeat and discoidin I-like domain-containing protein 3 | EDIL3 | 16.1 | 77.4 | 152.4 | Integrin | 80 | 46 | Cheng et al. 2019,70 Jiang et al. 2016,71 Aoyama et al. 1999,72 Kang et al. 2017,73 Mikkola et al. 2003,74 Przybyla, Lakins, and Weaver 2016.75 | Clark et al. 2013, 76 Faralli, Filla, and Peters 2019,77 Inoue and Tanihara 2013,78 Kwon and Tomarev 2011,79 Yan et al. 2020.80 | |
| Multiple epidermal growth factor-like domains protein 9 | MEGF9 | 2.3 | 4.4 | 11.5 | epidermal growth factor | 29 | 7 | Kratchmarova et al. 2005,81 Moore et al. 1997,82 Nakajima et al. 2007,83 Prabhakaran, Venugopal, and Ramakrishna 2009,84 Zhou et al. 2016.85 | Acharya et al. 2012,86 Wiederholt, Groth, and Strauss 1998,87 Wordinger et al. 1998.88 | |